Bill Text: HI HB1741 | 2012 | Regular Session | Amended

---

Bill Title: Prior Authorization; Insurance; Prescription Drugs

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2012-02-17 - (H) Report adopted. referred to the committee(s) on FIN as amended in HD 2 with none voting aye with reservations; none voting no (0) and Herkes, M. Lee excused (2). [HB1741 Detail]

Download: Hawaii-2012-HB1741-Amended.html

---

 

 

STAND. COM. REP. NO.  562-12

 

Honolulu, Hawaii

                , 2012

 

RE:   H.B. No. 1741

      H.D. 2

 

 

 

 

Honorable Calvin K.Y. Say

Speaker, House of Representatives

Twenty-Sixth State Legislature

Regular Session of 2012

State of Hawaii

 

Sir:

 

     Your Committee on Consumer Protection & Commerce, to which was referred H.B. No. 1741, H.D. 1, entitled:

 

"A BILL FOR AN ACT RELATING TO PRESCRIPTION DRUG,"

 

begs leave to report as follows:

 

     The purpose of this measure is to help increase the efficiency of health care in Hawaii by requiring the development and use of a uniform prior authorization form for prescription drugs.

 

     The Hawaii Medical Association, American Cancer Society, Faith Action for Community Equity, Epilepsy Foundation of Hawaii, National Multiple Sclerosis Society – Hawaii Office, GBS/CIDP Foundation International, American Academy of Private Physicians, Power of Pain Foundation, Hawaii Academy of Physician Assistants, Neuropathy Action Foundation, and a concerned individual supported this bill.  Ohana Health Plan supported the intent of this measure.  The Department of Commerce and Consumer Affairs, Hawaii Medical Service Association, CVS Caremark, and AlohaCare opposed this bill.  Kaiser Permanente Hawaii submitted comments.

 

     After careful consideration, your Committee has amended this bill by:

 

     (1)  Limiting the use of the uniform prior authorization form for prescription drugs to drugs that are prescribed for the treatment of diabetes or any form of cancer;

 

     (2)  Clarifying that the use of the uniform prior authorization form for prescription drugs applies to health insurance providers, mutual benefit societies, and health maintenance organizations;

 

     (3)  Providing for the repeal of this measure on July 1, 2017;

 

     (4)  Deleting the definition of "health care insurance provider"; and

 

     (5)  Making technical, nonsubstantive amendments for purposes of clarity, consistency, and style.

 

     As affirmed by the record of votes of the members of your Committee on Consumer Protection & Commerce that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 1741, H.D. 1, as amended herein, and recommends that it be referred to the Committee on Finance in the form attached hereto as H.B. No. 1741, H.D. 2.

 

 

Respectfully submitted on behalf of the members of the Committee on Consumer Protection & Commerce,

 

 

		____________________________ ROBERT N. HERKES, Chair